Community Resource

AASLD IDSA New Guidance

What’s New, Updates, and Changes to the Guidance This version of the guidance has been updated to reflect several important developments, including the recent approvals of glecaprevir/pibrentasvir and sofosbuvir/velpatasvir/voxilaprevir. Updated recommendations reflecting these approvals are Read more…

By HepCAP, ago
Treatment

New Hep C Drugs

HCVAdvocate.org posted news about another cheaper Hep C drug. Hopefully the market will continue to compete the prices down! Learn more about the FDA drug pipline at http://hcvadvocate.org/treatment/drug-pipeline/#FDA Mavyret

By HepCAP, ago